Millions of Californians Are Expected to Lose Medi-Cal Coverage Over Income Verifications

As the state verifies eligibility for its Medicaid program after a pandemic pause, up to 2.8 million Californians could be kicked off the rolls, officials say.

Read More

Department Of Labor Announces Rule Expanding Submission Requirements For Injury, Illness Data Provided By Employers In High-Hazard Industries

The U.S. Department of Labor today announced a final rule that will require certain employers in designated high-hazard industries to electronically submit injury and illness information – that they are already required to keep – to the department’s Occupational Safety and Health Administration. The final rule takes effect on Jan. 1, 2024, and now includes the ...

Read More

UnitedHealth’s Lower-Than-Feared Costs Lift Profit, Shares

UnitedHealth Group’s (UNH.N) quarterly profit beat Wall Street estimates on Friday as a smaller-than-expected jump in medical costs allayed fears that a resumption in long-delayed surgical procedures would hit profit growth. The company’s results allowed investors to breathe a sigh of relief following a $60-billion wipeout in industry market value last month, after UnitedHealth raised alarms about rising costs. ...

Read More

Washington’s Got A Thing For Telehealth

Flush times continue in Washington for telehealth advocates, marked most recently by victories in the House and at the Centers for Medicare and Medicaid Services last week. CMS proposed to boost payment rates to providers for the virtual care they give to Medicare patients in their homes. And a House subcommittee approved a bill that would ...

Read More

‘More Demand Than We Can Satisfy’: Why UCSF Wants To Gobble Up 2 S.F. Hospitals

Even as some San Francisco businesses lay off workers or leave town altogether, one mammoth local enterprise is looking to expand its presence in the city. UCSF Health, San Francisco’s largest medical center and second-largest employer after the city itself, hopes to get even bigger by buying a pair of money-losing hospitals — St. Mary’s Medical Center and Saint ...

Read More

Experimental Drug Slows Alzheimer’s Decline In Early-Stage Patients

An experimental Alzheimer’s drug from Eli Lilly was shown effective in slowing the disease’s progression by about a third — and more so when it was administered as early as possible, when patients only suffered mild cognitive impairment. Driving the news: The drug giant on Monday released full clinical trial results for its treatment donanemab, which could become the ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square